ARTICLE | Company News
JT licenses Chiron HCV target
March 7, 2001 8:00 AM UTC
CHIR granted Japan Tobacco (Tokyo, Japan) a non-exclusive license to develop and market small molecule therapeutics against a CHIR hepatitis C virus (HCV) drug target. ...